Apart from the viral parameters, other clinical and laboratory parameters like leukopenia, atypical lymphocytosis, fever, and deranged liver function test (elevated SGOT/SGPT/ bilirubin) should be considered while evaluating CMV reactivation in patients with COVID-19. This evidence concerns the gene GPT and COVID-19.